133 related articles for article (PubMed ID: 33801209)
1. The Selectivity for Tumor Cells of Nuclear-Directed Cytotoxic RNases Is Mediated by the Nuclear/Cytoplasmic Distribution of p27
García-Galindo G; Castro J; Matés J; Bravo M; Ribó M; Vilanova M; Benito A
Molecules; 2021 Mar; 26(5):. PubMed ID: 33801209
[TBL] [Abstract][Full Text] [Related]
2. Mislocalization of p27 to the cytoplasm of breast cancer cells confers resistance to anti-HER2 targeted therapy.
Zhao H; Faltermeier CM; Mendelsohn L; Porter PL; Clurman BE; Roberts JM
Oncotarget; 2014 Dec; 5(24):12704-14. PubMed ID: 25587029
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer.
Viglietto G; Motti ML; Bruni P; Melillo RM; D'Alessio A; Califano D; Vinci F; Chiappetta G; Tsichlis P; Bellacosa A; Fusco A; Santoro M
Nat Med; 2002 Oct; 8(10):1136-44. PubMed ID: 12244303
[TBL] [Abstract][Full Text] [Related]
4. Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axis.
Choi HH; Guma S; Fang L; Phan L; Ivan C; Baggerly K; Sood A; Lee MH
Cell Cycle; 2015; 14(14):2265-73. PubMed ID: 25945542
[TBL] [Abstract][Full Text] [Related]
5. NADPH oxidase 5 (NOX5)-induced reactive oxygen signaling modulates normoxic HIF-1α and p27
Antony S; Jiang G; Wu Y; Meitzler JL; Makhlouf HR; Haines DC; Butcher D; Hoon DS; Ji J; Zhang Y; Juhasz A; Lu J; Liu H; Dahan I; Konate M; Roy KK; Doroshow JH
Mol Carcinog; 2017 Dec; 56(12):2643-2662. PubMed ID: 28762556
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms underlying progesterone-induced cytoplasmic retention of p27 in breast cancer cells.
Wang HC; Lee WS
J Steroid Biochem Mol Biol; 2018 Oct; 183():202-209. PubMed ID: 29959971
[TBL] [Abstract][Full Text] [Related]
8. S100A7, Jab1, and p27
Granata M; Skarmoutsou E; Gangemi P; Mazzarino MC; D'Amico F
J Cell Biochem; 2019 Mar; 120(3):3384-3392. PubMed ID: 30203426
[TBL] [Abstract][Full Text] [Related]
9. Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer.
Rosen DG; Yang G; Cai KQ; Bast RC; Gershenson DM; Silva EG; Liu J
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):632-7. PubMed ID: 15701850
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic expression of p27(kip1) is associated with a favourable prognosis in colorectal cancer patients.
Watson NF; Durrant LG; Scholefield JH; Madjd Z; Scrimgeour D; Spendlove I; Ellis IO; Patel PM
World J Gastroenterol; 2006 Oct; 12(39):6299-304. PubMed ID: 17072952
[TBL] [Abstract][Full Text] [Related]
11. Post-translational regulation of the tumor suppressor p27(KIP1).
Vervoorts J; Lüscher B
Cell Mol Life Sci; 2008 Oct; 65(20):3255-64. PubMed ID: 18636226
[TBL] [Abstract][Full Text] [Related]
12. Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines.
Ling YH; Li T; Yuan Z; Haigentz M; Weber TK; Perez-Soler R
Mol Pharmacol; 2007 Aug; 72(2):248-58. PubMed ID: 17456787
[TBL] [Abstract][Full Text] [Related]
13. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
[TBL] [Abstract][Full Text] [Related]
14. Generation of new cytotoxic human ribonuclease variants directed to the nucleus.
Vert A; Castro J; Ruiz-Martínez S; Tubert P; Escribano D; Ribó M; Vilanova M; Benito A
Mol Pharm; 2012 Oct; 9(10):2894-902. PubMed ID: 22957849
[TBL] [Abstract][Full Text] [Related]
15. PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer.
Prasad SB; Yadav SS; Das M; Modi A; Kumari S; Pandey LK; Singh S; Pradhan S; Narayan G
Cell Oncol (Dordr); 2015 Jun; 38(3):215-25. PubMed ID: 25821107
[TBL] [Abstract][Full Text] [Related]
16. Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in epithelial ovarian cancer.
Hurteau JA; Allison BM; Brutkiewicz SA; Goebl MG; Heilman DK; Bigsby RM; Harrington MA
Gynecol Oncol; 2001 Nov; 83(2):292-8. PubMed ID: 11606087
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in human colon cancer.
Sgambato A; Ratto C; Faraglia B; Merico M; Ardito R; Schinzari G; Romano G; Cittadini AR
Mol Carcinog; 1999 Nov; 26(3):172-9. PubMed ID: 10559792
[TBL] [Abstract][Full Text] [Related]
18. PCBP1 depletion promotes tumorigenesis through attenuation of p27
Shi H; Li H; Yuan R; Guan W; Zhang X; Zhang S; Zhang W; Tong F; Li L; Song Z; Wang C; Yang S; Wang H
J Exp Clin Cancer Res; 2018 Aug; 37(1):187. PubMed ID: 30086790
[TBL] [Abstract][Full Text] [Related]
19. p27(Kip1) signaling: Transcriptional and post-translational regulation.
Hnit SS; Xie C; Yao M; Holst J; Bensoussan A; De Souza P; Li Z; Dong Q
Int J Biochem Cell Biol; 2015 Nov; 68():9-14. PubMed ID: 26279144
[TBL] [Abstract][Full Text] [Related]
20. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex.
Tomoda K; Kubota Y; Arata Y; Mori S; Maeda M; Tanaka T; Yoshida M; Yoneda-Kato N; Kato JY
J Biol Chem; 2002 Jan; 277(3):2302-10. PubMed ID: 11704659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
